BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9323079)

  • 1. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation.
    Smith RC; Wills KN; Antelman D; Perlman H; Truong LN; Krasinski K; Walsh K
    Circulation; 1997 Sep; 96(6):1899-905. PubMed ID: 9323079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation.
    Wills KN; Mano T; Avanzini JB; Nguyen T; Antelman D; Gregory RJ; Smith RC; Walsh K
    Gene Ther; 2001 Dec; 8(24):1847-54. PubMed ID: 11821938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques.
    Bennett MR; Macdonald K; Chan SW; Boyle JJ; Weissberg PL
    Circ Res; 1998 Apr; 82(6):704-12. PubMed ID: 9546379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty.
    Claudio PP; Fratta L; Farina F; Howard CM; Stassi G; Numata S; Pacilio C; Davis A; Lavitrano M; Volpe M; Wilson JM; Trimarco B; Giordano A; Condorelli G
    Circ Res; 1999 Nov; 85(11):1032-9. PubMed ID: 10571534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.
    Chang MW; Barr E; Lu MM; Barton K; Leiden JM
    J Clin Invest; 1995 Nov; 96(5):2260-8. PubMed ID: 7593612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
    Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
    Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1.
    Shelat HS; Liu TJ; Hickman-Bick DL; Barnhart MK; Vida T; Dillard PM; Willerson JT; Zoldhelyi P
    Circulation; 2001 Jan; 103(3):407-14. PubMed ID: 11157693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
    Kim TA; Ravitz MJ; Wenner CE
    J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.
    Lamfers ML; Aalders MC; Grimbergen JM; de Vries MR; Kockx MM; van Hinsbergh VW; Quax PH
    Vascul Pharmacol; 2002 Dec; 39(6):293-301. PubMed ID: 14567067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation.
    Reil TD; Kashyap VS; Sarkar R; Freishlag J; Gelabert HA
    J Surg Res; 2000 Jul; 92(1):108-13. PubMed ID: 10864490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated forkhead transcription factor inhibits neointimal hyperplasia after angioplasty through induction of p27.
    Park KW; Kim DH; You HJ; Sir JJ; Jeon SI; Youn SW; Yang HM; Skurk C; Park YB; Walsh K; Kim HS
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):742-7. PubMed ID: 15662024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB.
    Muthukkumar S; Sells SF; Crist SA; Rangnekar VM
    J Biol Chem; 1996 Mar; 271(10):5733-40. PubMed ID: 8621439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
    Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
    Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.
    Goukassian D; Sanz-González SM; Pérez-Roger I; Font de Mora J; Ureña J; Andrés V
    Br J Pharmacol; 2001 Apr; 132(7):1597-605. PubMed ID: 11264255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.